Liquidia LQDA
NASDAQ LQDA
$71.60 -3.73 (-4.95%)
At close: Aug 20, 2026 · 3:06 PM UTC

Liquidia (LQDA) Total Debt Growth (3y) (2022)

Liquidia (LQDA) Total Debt Growth (3y) (2022) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt Growth (3y) (Qtr)
1 Haleon 43.86 Bn 42.90 Bn - 15.43%
2 Teva Pharmaceutical Industries 43.19 Bn 39.54 Bn 2.15 Bn -7.08%
3 Zoetis 31.46 Bn 29.79 Bn 1.05 Bn 11.33%
4 Takeda Pharmaceutical 28.57 Bn 22.77 Bn 5.10 Bn -3.67%
5 United Therapeutics 22.15 Bn 19.49 Bn 683.80 Mn -
6 Viatris 18.75 Bn 17.86 Bn 1.46 Bn -10.43%
7 Neurocrine Biosciences 15.50 Bn 15.11 Bn 935.80 Mn -
8 Elanco Animal Health 11.71 Bn 11.18 Bn 798.00 Mn -13.72%
9 Dr Reddys Laboratories 10.12 Bn 9.95 Bn - 92.83%
10 Liquidia 6.36 Bn 6.08 Bn 160.92 Mn 56.61%

Historic Data

Download Data
DateValue
Dec 31, 2022 7.78%